Vol. 1, Issue 11, Part P (2015)

Background and Objectives: To evaluate the efficacy of a pure tissue-based strategy in comparing the primary inguinal hernia therapy with the conventional Lichtenstein repair.

Methods: For our investigation, a total of 150 cases were separated into two groups. Group L in Lichtenstein consisted of 75 patients, while group D in Desarda also had 75 patients. The primary determinant of the outcome was the occurrence of inguinal hernia recurrence within a one-year timeframe. The duration between the surgical intervention and the closure of the skin was considered as a secondary outcome factor. Postoperative pain scores were computed using the visual analog scale. The duration required to resume regular activities at home was computed. The patient experienced various postoperative complications, such as cord edema, groin pain, seroma, fever, wound infections, and persistent pain.

Results: Each arm in the study exhibited one recurrence after a 15-month mean follow-up period (P=1). In the Lichtenstein group, the operational time was 73.89+12.63 minutes, while the repair time was 72.60+13.89 minutes (P=0.508). In comparison to the Lichtenstein group, the group experienced significantly lower postoperative pain within the first seven days after surgery (P=0.09). Additionally, the group had a significantly shorter time to resume routine activities at home compared to the Lichtenstein group (P=0.001). However, there was no statistically significant difference in the rates of post-operative complications between the two trial arms.

Conclusion: Comparable outcomes have been observed between the Desarda approach and conventional Lichtenstein surgeries in the treatment of inguinal hernias. A mesh is not utilized in the Desarda method. Patients who undergo Desarda's surgical treatment recover from it more quickly than those who receive the usual Lichtenstein mesh repair. The occurrence of postoperative pain is reduced, while the standards of the method remain unchanged. The Desarda approach may increase the selection of tissue-based groyne hernia therapy alternatives.